新华财经上海11月8日电（记者王淑娟）作为推动高水平对外开放的重要平台，进博会上的医疗器械及 医药保健展区每届都汇聚了全球顶尖医疗科技企业，集中展示前沿医疗创新成果。不少跨国制药和器械 公司都是进博会的八年"全勤生"。今年有哪些新风向？ 通过进博会这个前沿医疗创新成果亮相的窗口，可以看到，进博会的"溢出效应"持续改写创新药进入中 国市场的速度。8年间，不少创新药物依托进博会的平台实现"华丽转身"，加速走进中国患者的生活。 我国上半年批准创新药43个、创新医疗器械45个，同比分别增长59%和87%，政策红利正在转化为产业 发展动力。这一趋势在第八届进博会上得到集中体现。 值得关注的是，国家医保局首次在进博会设展，主题为"中国医保，全球医药重要采购方"，展示医保超 大规模覆盖与采购成果，以及对全球创新药械的持续购买和支持医药创新的立场。 赛诺菲已是第八年参加进博会，其展品"达必妥"（度普利尤单抗注射液）是进博会溢出效应的最佳见证 者。这款药物从首次亮相、获批上市到纳入国家医保目录，再到不断拓展新适应症，经历了进博会的全 流程催化。 默沙东在第八届进博会上展示了其在中国境内已获批的约30种药物和疫苗，覆盖肿瘤、抗感 ...

图片1_副本 第八届进博会的展馆内，赛诺菲聚焦"健康中国"战略重点关注的心血管、代谢、呼吸、肿瘤四大慢病， 以及免疫炎症、移植、罕见病等全球患者亟需的领域，集中展示了十款"同类首创"或"同类最佳"的创新 药物和疫苗以及多款潜在重磅产品的全球研发管线，生动呈现赛诺菲助力"健康中国"建设所做的积极贡 献。 赛诺菲大中华区总裁施旺表示："面对日益多元的健康需求，本届进博会上，赛诺菲围绕'健康中国'战 略重点，带来一系列前沿创新成果。其中，两款心血管领域的突破性疗法迎来全球首秀。中国是赛诺菲 全球第二大市场。我们长期看好中国市场前景，对医疗健康领域的未来充满信心。未来，我们将持续深 耕中国，通过深化本土布局、加码创新投入，在中国共享时代机遇、共创生命奇迹。" 拓展本土协作，助力行业高质量发展 此次进博会，赛诺菲紧扣"追寻奇迹，筑梦为你"这一主题，布局"研发驱动，AI赋能"、"追寻科学奇 迹"、"助力健康中国"三大展区，全方位呈现赛诺菲在引领科学创新、满足健康未尽之需，以及深化中 国布局等方面的丰硕成果与卓越成就。 赛诺菲还集中展示了多款近一年获批的"进博宝宝"，包括全球首个且唯一用于延缓1型糖尿病进展的创 新药特瑞可 ...

Group 1 - The eighth China International Import Expo (CIIE) is set to take place from November 5 to 10 in Shanghai, with the theme "New Era, Shared Future" [1] - The expo will feature six major exhibition areas, including an upgraded "Automobile and Smart Mobility Exhibition Area" and a focus on global top medical technology achievements in the medical exhibition area [2] - A special area for least developed countries' products will be established for the first time, promoting the use of "zero tariff" policies for enterprises from these nations [2] Group 2 - New initiatives for enhancing supply-demand matching efficiency include tailored strategies for groups, an online registration system for group visits, and a comprehensive online supply-demand platform [3] - The exhibition will optimize digital services and reduce some service fees to enhance the overall experience for exhibitors [3] Group 3 - Over 50 countries and international organizations have confirmed participation, with Sweden and the UAE serving as guest countries, and Kyrgyzstan making its debut at the expo [4] - A record number of enterprises from Canada, Malaysia, and New Zealand will participate, with new provincial and municipal representations from Saskatchewan and Almaty [4] Group 4 - Boston Scientific will showcase several innovative products, including the Intera 3000 liver perfusion pump and the FARAPULSE ablation system, emphasizing the importance of the expo for deepening cooperation in China [5] - Sanofi will highlight its innovative drugs, including Dupixent and the first RSV prevention drug for infants, showcasing the expo as a platform for accelerating innovation [5] Group 5 - The expo aims to strengthen the three key characteristics of "innovation-driven, consumption upgrade, and inclusive development," contributing to global economic recovery through international procurement and investment promotion [6]